CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Lenire Now Included in U.S. ENT Clinical Practice Guidelines - First New Treatment Added by American Academy of Otolaryngology Since Establishment of the Academy's Tinnitus Guidelines

RegulatorypositiveLenirePositive
AI Analysis

Summary

The American Academy of Otolaryngology – Head and Neck Surgery Foundation added Lenire (bimodal neuromodulation) as a treatment option in its Clinical Practice Guidelines for Tinnitus for the first time. Lenire is the only new treatment recommendation added to the guidelines.

Outcome Details

Lenire included as a treatment option in the AAO-HNSF Clinical Practice Guidelines for Tinnitus; the only new treatment recommendation added to the guidelines.

Importance:5/10
Sentiment:
0.70
tinnitusmedical deviceneuromodulationclinical practice guidelinesAAO-HNSFENT
Related Companies

Read the original article

Published by PR Newswire Biotech on October 16, 2026 1:38 PM

Read Original